{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:39:01Z","timestamp":1776944341460,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.yjmcc.2015.05.007","type":"journal-article","created":{"date-parts":[[2015,5,16]],"date-time":"2015-05-16T12:08:01Z","timestamp":1431778081000},"page":"37-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Losartan treatment attenuates tumor-induced myocardial dysfunction"],"prefix":"10.1016","volume":"85","author":[{"given":"Sarah C.W.","family":"Stevens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Velten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dane J.","family":"Youtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runfeng","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Reiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabahattin","family":"Bicer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond D.","family":"Devine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna O.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6658-7770","authenticated-orcid":false,"given":"Loren E.","family":"Wold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2015.05.007_bb0005","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ctrv.2013.11.007","article-title":"Towards a simple objective framework for the investigation and treatment of cancer cachexia: the Glasgow Prognostic Score","volume":"40","author":"Douglas","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0010","first-page":"1321","article-title":"Evidence for cardiac atrophic remodeling in cancer-induced cachexia in mice","volume":"39","author":"Tian","year":"2011","journal-title":"Int J Oncol"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0015","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.lfs.2010.12.010","article-title":"Myocardial dysfunction in an animal model of cancer cachexia","volume":"88","author":"Xu","year":"2011","journal-title":"Life Sci"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12012-007-0016-2","article-title":"Pathophysiology and diagnosis of cancer drug induced cardiomyopathy","volume":"7","author":"Zuppinger","year":"2007","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0025","first-page":"347","article-title":"Cardiac alterations in cancer-induced cachexia in mice","volume":"37","author":"Tian","year":"2010","journal-title":"Int J Oncol"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0030","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.LAB.0000017372.76297.EB","article-title":"Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways","volume":"82","author":"Tamarat","year":"2002","journal-title":"Lab Invest"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0035","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nnano.2012.45","article-title":"Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner","volume":"7","author":"Chauhan","year":"2012","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0040","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jacc.2013.02.072","volume":"61","author":"Bosch","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0045","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","article-title":"Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition","volume":"114","author":"Cardinale","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0050","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/eurheartj\/eht302","article-title":"Prevention of liver cancer cachexia-induced cardiac wasting and heart failure","volume":"35","author":"Springer","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0055","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/MPA.0000000000000125","article-title":"Antitumor effect of angiotensin II type 1 receptor blocker losartan for orthotopic rat pancreatic adenocarcinoma","volume":"43","author":"Kim","year":"2014","journal-title":"Pancreas"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0060","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1210\/endo.142.4.8082","article-title":"Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I","volume":"142","author":"Brink","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0065","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1172\/JCI118698","article-title":"Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism","volume":"97","author":"Brink","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0070","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbrc.2011.04.122","article-title":"Angiotensin II induced catabolic effect and muscle atrophy are redox dependent","volume":"409","author":"Semprun-Prieto","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/MAJ.0b013e318222e620","article-title":"Angiotensin II, oxidative stress and skeletal muscle wasting","volume":"342","author":"Sukhanov","year":"2011","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0080","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bjc.6602725","article-title":"Angiotensin II directly induces muscle protein catabolism through the ubiquitin\u2013proteasome proteolytic pathway and may play a role in cancer cachexia","volume":"93","author":"Sanders","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0085","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/ijc.28128","article-title":"Inhibition of the renin\u2013angiotensin system improves physiological outcomes in mice with mild or severe cancer cachexia","volume":"133","author":"Murphy","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0090","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1161\/CIRCHEARTFAILURE.112.966580","article-title":"Cardiovascular remodeling in response to long-term exposure to fine particulate matter air pollution","volume":"5","author":"Wold","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0095","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/01.CIR.43.4.480","article-title":"Left ventricular volumes and ejection fraction by echocardiography","volume":"43","author":"Pombo","year":"1971","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0100","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.lfs.2008.09.026","article-title":"Cytoskeletal remodeling of desmin is a more accurate measure of cardiac dysfunction than fibrosis or myocyte hypertrophy","volume":"83","author":"Monreal","year":"2008","journal-title":"Life Sci"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0105","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1006\/bbrc.2000.2353","article-title":"Diabetes enhances acetaldehyde-induced depression of cardiac myocyte contraction","volume":"269","author":"Ren","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0110","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.cdp.2004.07.008","article-title":"Doxorubicin induces cardiomyocyte dysfunction via a p38 MAP kinase-dependent oxidative stress mechanism","volume":"29","author":"Wold","year":"2005","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0115","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.freeradbiomed.2005.12.009","article-title":"Metallothionein alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of Ca2+ cycling proteins, NADPH oxidase, poly(ADP-Ribose) polymerase and myosin heavy chain isozyme","volume":"40","author":"Wold","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0120","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1113\/jphysiol.2005.103267","article-title":"Regional differences in spontaneous Ca2+ spark activity and regulation in cat atrial myocytes","volume":"572","author":"Sheehan","year":"2006","journal-title":"J Physiol"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0125","doi-asserted-by":"crossref","first-page":"L478","DOI":"10.1152\/ajplung.00361.2007","article-title":"Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells","volume":"294","author":"Kode","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0130","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.canlet.2012.10.006","article-title":"Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer","volume":"328","author":"Chen","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0135","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/FJC.0b013e31823f888f","article-title":"Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4weeks of pressure overload in mice","volume":"59","author":"Zou","year":"2012","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0140","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1161\/01.RES.82.11.1145","article-title":"Angiotensin II stimulation in vitro induces hypertrophy of normal and postinfarcted ventricular myocytes","volume":"82","author":"Liu","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0145","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.1073\/pnas.0802690105","article-title":"Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance","volume":"105","author":"Jayasooriya","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0150","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/jcb.22163","article-title":"Cell-cycle-dependent PC-PLC regulation by APC\/C(Cdc20)-mediated ubiquitin\u2013proteasome pathway","volume":"107","author":"Fu","year":"2009","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0155","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ajpath.2010.12.009","article-title":"NF-kappaB inhibition protects against tumor-induced cardiac atrophy in vivo","volume":"178","author":"Wysong","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0160","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.lfs.2011.01.009","article-title":"Angiotensin receptor blockade improves the net balance of cardiac Ca(2+) handling-related proteins in sympathetic hyperactivity-induced heart failure","volume":"88","author":"Ferreira","year":"2011","journal-title":"Life Sci"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0165","doi-asserted-by":"crossref","first-page":"H1217","DOI":"10.1152\/ajpheart.2001.281.3.H1217","article-title":"Loaded shortening and power output in cardiac myocytes are dependent on myosin heavy chain isoform expression","volume":"281","author":"Herron","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0170","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1161\/01.RES.0000022879.57270.11","article-title":"Small amounts of alpha-myosin heavy chain isoform expression significantly increase power output of rat cardiac myocyte fragments","volume":"90","author":"Herron","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0175","doi-asserted-by":"crossref","first-page":"H801","DOI":"10.1152\/ajpheart.01227.2004","article-title":"Power output is linearly related to MyHC content in rat skinned myocytes and isolated working hearts","volume":"289","author":"Korte","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0180","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/CIRCRESAHA.110.220699","article-title":"Effects of chronic atrial fibrillation on active and passive force generation in human atrial myofibrils","volume":"107","author":"Belus","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0185","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1172\/JCI200420174","article-title":"Cancer cachexia is regulated by selective targeting of skeletal muscle gene products","volume":"114","author":"Acharyya","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0190","doi-asserted-by":"crossref","first-page":"H1997","DOI":"10.1152\/ajpheart.00671.2004","article-title":"Effects of pre-, peri-, and postmyocardial infarction treatment with losartan in rats: effect of dose on survival, ventricular arrhythmias, function, and remodeling","volume":"288","author":"Pourdjabbar","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0195","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1152\/physiolgenomics.00165.2004","article-title":"Cardiac gene expression profile in rats with terminal heart failure and cachexia","volume":"20","author":"Wellner","year":"2005","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0200","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1111\/j.1582-4934.2012.01623.x","article-title":"Reversal of subcellular remodelling by losartan in heart failure due to myocardial infarction","volume":"16","author":"Babick","year":"2012","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0205","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/01.RES.0000034710.46739.C0","article-title":"Myofilament calcium sensitivity and cardiac disease: insights from troponin I isoforms and mutants","volume":"91","author":"Westfall","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0210","doi-asserted-by":"crossref","first-page":"H1451","DOI":"10.1152\/ajpheart.00238.2013","article-title":"COX-1-derived PGE2 and PGE2 type 1 receptors are vital for angiotensin II-induced formation of reactive oxygen species and Ca(2+) influx in the subfornical organ","volume":"305","author":"Wang","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0215","doi-asserted-by":"crossref","first-page":"28668","DOI":"10.1074\/jbc.M113.470971","article-title":"Nox4 NADPH oxidase mediates peroxynitrite-dependent uncoupling of endothelial nitric\u2013oxide synthase and fibronectin expression in response to angiotensin II: role of mitochondrial reactive oxygen species","volume":"288","author":"Lee","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0220","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1089\/ars.2012.4604","article-title":"Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease","volume":"19","author":"Dikalov","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.yjmcc.2015.05.007_bb0225","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1038\/ncomms3516","article-title":"Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels","volume":"4","author":"Chauhan","year":"2013","journal-title":"Nat Commun"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282815001558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282815001558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T02:16:37Z","timestamp":1566699397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282815001558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":45,"alternative-id":["S0022282815001558"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2015.05.007","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Losartan treatment attenuates tumor-induced myocardial dysfunction","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2015.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}